Dysregulated cholesterol regulatory genes in hepatocellular carcinoma

被引:0
|
作者
Dan Cao
Huan Liu
机构
[1] Affiliated Hospital of North Sichuan Medical College,Department of Respiratory and Critical Care Medicine
[2] West China Hospital of Sichuan University,Center of Infectious Diseases
来源
European Journal of Medical Research | / 28卷
关键词
Hepatocellular carcinoma; Cholesterol; Tumorigenesis; Therapy;
D O I
暂无
中图分类号
学科分类号
摘要
Cholesterol is an indispensable component in mammalian cells, and cholesterol metabolism performs important roles in various biological activities. In addition to the Warburg effect, dysregulated cholesterol metabolism is one of the metabolic hallmarks of several cancers. It has reported that reprogrammed cholesterol metabolism facilitates carcinogenesis, metastasis, and drug-resistant in various tumors, including hepatocellular carcinoma (HCC). Some literatures have reported that increased cholesterol level leads to lipotoxicity, inflammation, and fibrosis, ultimately promoting the development and progression of HCC. Contrarily, other clinical investigations have demonstrated a link between higher cholesterol level and lower risk of HCC. These incongruent findings suggest that the connection between cholesterol and HCC is much complicated. In this report, we summarize the roles of key cholesterol regulatory genes including cholesterol biosynthesis, uptake, efflux, trafficking and esterification in HCC. In addition, we discuss promising related therapeutic targets for HCC.
引用
收藏
相关论文
共 50 条
  • [41] SERUM-CHOLESTEROL AND SQUALENE IN HEPATOCELLULAR CARCINOMA
    HIRAYAMA, C
    YAMANISHI, Y
    IRISA, T
    CLINICA CHIMICA ACTA, 1979, 91 (01) : 53 - 57
  • [42] Cholesterol and hepatocellular carcinoma risk: reliable and actionable?
    Alain Braillon
    British Journal of Cancer, 2021, 124 : 1339 - 1339
  • [43] Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model
    Del Vecchio, Filippo
    Gallo, Francesco
    Di Marco, Antinisca
    Mastroiaco, Valentina
    Caianiello, Pasquale
    Zazzeroni, Francesca
    Alesse, Edoardo
    Tessitore, Alessandra
    BMC BIOINFORMATICS, 2015, 16
  • [44] Bioinformatics approach to predict target genes for dysregulated microRNAs in hepatocellular carcinoma: study on a chemically-induced HCC mouse model
    Filippo Del Vecchio
    Francesco Gallo
    Antinisca Di Marco
    Valentina Mastroiaco
    Pasquale Caianiello
    Francesca Zazzeroni
    Edoardo Alesse
    Alessandra Tessitore
    BMC Bioinformatics, 16
  • [45] Recurrence of hepatocellular carcinoma: It's in the genes?
    Perkins, James D.
    LIVER TRANSPLANTATION, 2007, 13 (03) : 464 - 465
  • [46] Identification of Prognostic Genes in Hepatocellular Carcinoma
    Bai, Wenhui
    Cheng, Li
    Xiong, Liangkun
    Wang, Maoming
    Liu, Hao
    Yu, Kaihuan
    Wang, Weixing
    INTERNATIONAL JOURNAL OF GENERAL MEDICINE, 2022, 15 : 2895 - 2904
  • [47] IDENTIFICATION OF REGULATORY MICRORNAS FOR HEPATOCELLULAR CARCINOMA PROGRESSION
    Woo, Hyun Goo
    Coulouarn, Cedric
    Thorgeirsson, Snorri S.
    HEPATOLOGY, 2010, 52 (04) : 580A - 580A
  • [48] Comprehensive analysis of potential prognostic genes for the construction of a competing endogenous RNA regulatory network in hepatocellular carcinoma
    Yue, Chaosen
    Ren, Yaoyao
    Ge, Hua
    Liang, Chaojie
    Xu, Yingchen
    Li, Guangming
    Wu, Jixiang
    ONCOTARGETS AND THERAPY, 2019, 12 : 561 - 576
  • [49] Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications
    Hsi-Huang Tseng
    Jan-Gowth Chang
    Yaw-Huei Hwang
    Kun-Tu Yeh
    Yao-Li Chen
    Hsin-Su Yu
    Journal of Cancer Research and Clinical Oncology, 2009, 135 : 1413 - 1420
  • [50] Expression of hepcidin and other iron-regulatory genes in human hepatocellular carcinoma and its clinical implications
    Tseng, Hsi-Huang
    Chang, Jan-Gowth
    Hwang, Yaw-Huei
    Yeh, Kun-Tu
    Chen, Yao-Li
    Yu, Hsin-Su
    JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2009, 135 (10) : 1413 - 1420